Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression

Anna Bagnato1, Laura Rosanò, Francesca Spinella

  • 1Laboratory of Molecular Pathology and Ultrastructure, Regina Elena Cancer Institute, Via delle Messi d'Oro 156, 00158 Rome, Italy. bagnato@ifo.it

Cancer Research
|February 20, 2004
PubMed

Insights

Activation of the endothelin B receptor (ET(B)R) by endothelin-1 and ET-3 promotes melanoma progression by altering cell adhesion and increasing invasion. An ET(B)R antagonist inhibited melanoma growth, suggesting a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • The endothelin B receptor (ET(B)R) is implicated in cutaneous melanoma progression.
  • ET(B)R presents a potential therapeutic target for melanoma treatment.

Purpose of the Study:

  • To investigate the role of ET(B)R activation in melanoma cell signaling and progression.
  • To evaluate the therapeutic potential of ET(B)R antagonists in melanoma.

Main Methods:

  • Melanoma cells were treated with endothelin-1 (ET-1) and ET-3 to activate ET(B)R.
  • Changes in cell adhesion molecules (E-cadherin, N-cadherin), intercellular communication (connexin 43), integrin expression, and matrix metalloproteinases (MMPs) were assessed.
  • Downstream signaling pathways (FAK, ERK1/2) were analyzed.
  • Melanoma growth was evaluated in vivo using an ET(B)R antagonist (A-192621) in nude mice.

Main Results:

  • ET(B)R activation led to decreased E-cadherin and increased N-cadherin expression, disrupting cell adhesion.
  • Intercellular communication was inhibited by 60% via connexin 43 phosphorylation.
  • Increased expression of alpha(v)beta(3) and alpha(2)beta(1) integrins, MMP-2, MMP-9, and membrane type-1-MMP was observed.
  • Downstream activation of FAK and ERK1/2 pathways promoted cell proliferation, migration, and invasion.
  • The ET(B)R antagonist A-192621 significantly inhibited melanoma tumor growth in vivo.

Conclusions:

  • ET(B)R activation by ET-1 and ET-3 drives melanoma progression through modulation of cell adhesion, communication, and invasion pathways.
  • Targeting ET(B)R signaling offers a promising novel therapeutic strategy for cutaneous melanoma.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...